These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 19462760)

  • 1. [Oncogenic mutations of ALK are associated with tumorigenesis of neuroblastoma].
    Takita J; Ogawa S
    Tanpakushitsu Kakusan Koso; 2009 May; 54(6):742-7. PubMed ID: 19462760
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncogenic mutations of ALK kinase in neuroblastoma.
    Chen Y; Takita J; Choi YL; Kato M; Ohira M; Sanada M; Wang L; Soda M; Kikuchi A; Igarashi T; Nakagawara A; Hayashi Y; Mano H; Ogawa S
    Nature; 2008 Oct; 455(7215):971-4. PubMed ID: 18923524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
    Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
    Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapy.
    Martinsson T; Eriksson T; Abrahamsson J; Caren H; Hansson M; Kogner P; Kamaraj S; Schönherr C; Weinmar J; Ruuth K; Palmer RH; Hallberg B
    Cancer Res; 2011 Jan; 71(1):98-105. PubMed ID: 21059859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients.
    Passoni L; Longo L; Collini P; Coluccia AM; Bozzi F; Podda M; Gregorio A; Gambini C; Garaventa A; Pistoia V; Del Grosso F; Tonini GP; Cheng M; Gambacorti-Passerini C; Anichini A; Fossati-Bellani F; Di Nicola M; Luksch R
    Cancer Res; 2009 Sep; 69(18):7338-46. PubMed ID: 19723661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-trans retinoic acid downregulates ALK in neuroblastoma cell lines and induces apoptosis in neuroblastoma cell lines with activated ALK.
    Futami H; Sakai R
    Cancer Lett; 2010 Nov; 297(2):220-5. PubMed ID: 20576349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ALK, a key gene in the pathogenesis of neuroblastoma].
    Janoueix-Lerosey I; Delattre O
    Med Sci (Paris); 2009 Apr; 25(4):330-2. PubMed ID: 19409178
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of missense mutations on structure and interaction of anaplastic Lymphoma kinase (ALK) in neuroblastom.
    Kanwal H; Khan MH; Rashid H
    Pak J Pharm Sci; 2013 May; 26(3):611-6. PubMed ID: 23625438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours.
    Carén H; Abel F; Kogner P; Martinsson T
    Biochem J; 2008 Dec; 416(2):153-9. PubMed ID: 18990089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?
    Mathivet T; Mazot P; Vigny M
    Cell Signal; 2007 Dec; 19(12):2434-43. PubMed ID: 17904822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells.
    Schönherr C; Yang HL; Vigny M; Palmer RH; Hallberg B
    Oncogene; 2010 May; 29(19):2817-30. PubMed ID: 20190816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and genomics of neuroblastoma.
    Capasso M; Diskin SJ
    Cancer Treat Res; 2010; 155():65-84. PubMed ID: 20517688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase gene.
    Kelleher FC; McDermott R
    Eur J Cancer; 2010 Sep; 46(13):2357-68. PubMed ID: 20451371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Discovery of a gene mutation associated with familial neuroblastoma].
    Nau JY
    Rev Med Suisse; 2008 Sep; 4(169):1888. PubMed ID: 18831412
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitors of protein kinases induce differentiation in human neuroblastoma cell lines.
    Rocchi P; Ferreri AM; Simone G; Magrini E; Cavallazzi L; Paolucci G
    Anticancer Res; 1995; 15(4):1381-5. PubMed ID: 7654025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine phosphorylation of NPM-ALK, which is dependent on the auto-activation of the kinase activation loop, contributes to its oncogenic potential.
    Wang P; Wu F; Zhang J; McMullen T; Young LC; Ingham RJ; Li L; Lai R
    Carcinogenesis; 2011 Feb; 32(2):146-53. PubMed ID: 21045017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ALK signaling for cancer therapy.
    Mossé YP; Wood A; Maris JM
    Clin Cancer Res; 2009 Sep; 15(18):5609-14. PubMed ID: 19737948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathogenesis of peripheral neuroblastic tumors.
    Janoueix-Lerosey I; Schleiermacher G; Delattre O
    Oncogene; 2010 Mar; 29(11):1566-79. PubMed ID: 20101209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of regulation of nuclear proto-oncogenes MYCN and MYB in retinoic acid treated neuroblastoma cells.
    Thiele CJ
    Prog Clin Biol Res; 1991; 366():151-6. PubMed ID: 2068135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.